Compounds > dazoxiben
Page last updated: 2024-08-23

dazoxiben and Coronary Disease

dazoxiben has been researched along with Coronary Disease in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19909 (81.82)18.7374
1990's2 (18.18)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gormsen, J; Juhl, A; Knudsen, JB1
Thaulow, E1
Deckmyn, H; Vermylen, J1
Cairns, J; Gyde, OH; Kuan, P; Reuben, SR1
Lucchesi, BR; Schumacher, WA1
Dale, J; Myhre, E; Thaulow, E1
Buja, LM; Bush, LR; Campbell, WB; Tilton, GD; Willerson, JT1
Burke, SE; Lefer, AM; Smith, GM; Smith, JB1
Davidson, JF; Hutton, I; Rankin, AC; Tweddel, AC; Walker, ID1
Anderson, HV; Buja, LM; De Clerck, F; Golino, P; NcNatt, JM; Rosolowsky, M; Willerson, JT; Yao, SK1
Dorigo, O; Kübler, W; Neumann, FJ; Parekh, N; Steinhausen, M; Tiefenbacher, C; Tillmanns, H; Zimmermann, R1

Trials

1 trial(s) available for dazoxiben and Coronary Disease

ArticleYear
Effects of dazoxiben on exercise performance in chronic stable angina.
    British journal of clinical pharmacology, 1983, Volume: 15 Suppl 1

    Topics: Angina Pectoris; Coronary Disease; Double-Blind Method; Humans; Imidazoles; Nitroglycerin; Oxidoreductases; Physical Exertion; Platelet Aggregation; Thrombelastography; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes

1983

Other Studies

10 other study(ies) available for dazoxiben and Coronary Disease

ArticleYear
Thromboxane synthase inhibition in patients with atherosclerotic heart disease.
    Lancet (London, England), 1981, Jul-25, Volume: 2, Issue:8239

    Topics: Coronary Disease; Humans; Imidazoles; Oxidoreductases; Platelet Aggregation; Thromboxane-A Synthase

1981
Platelet function in blood from the coronary sinus in patients with arteriosclerotic heart disease.
    Thrombosis and haemostasis, 1983, Oct-31, Volume: 50, Issue:3

    Topics: Adenosine Diphosphate; Aspirin; beta-Thromboglobulin; Blood Platelets; Collagen; Coronary Disease; Coronary Vessels; Humans; Imidazoles; In Vitro Techniques; Male; Platelet Aggregation; Platelet Count; Vena Cava, Superior

1983
Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observations.
    British journal of clinical pharmacology, 1983, Volume: 15 Suppl 1

    Topics: Adult; Aged; Blood Platelets; Calcium; Coronary Disease; Cyclic AMP; Female; Humans; Imidazoles; Oxidoreductases; Platelet Aggregation; Prostaglandin Endoperoxides; Thromboxane-A Synthase; Time Factors

1983
Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
    The Journal of pharmacology and experimental therapeutics, 1983, Volume: 227, Issue:3

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Hyperemia; Imidazoles; Male; Oxidoreductases; Platelet Aggregation; Thromboxane B2; Thromboxane-A Synthase; Time Factors; Vasodilation

1983
Effects of a selective thromboxane synthetase inhibitor, dazoxiben, and of acetylsalicylic acid on myocardial ischemia in patients with coronary artery disease.
    The American journal of cardiology, 1984, May-01, Volume: 53, Issue:9

    Topics: Aspirin; Cardiac Pacing, Artificial; Coronary Disease; Humans; Imidazoles; Lactates; Male; Middle Aged; Myocardium; Oxidoreductases; Platelet Aggregation; Thromboxane-A Synthase

1984
Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
    Circulation, 1984, Volume: 69, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 6-Ketoprostaglandin F1 alpha; Animals; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Female; Hemodynamics; Imidazoles; Male; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Thromboxane B2

1984
Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor.
    British journal of clinical pharmacology, 1983, Volume: 15 Suppl 1

    Topics: Animals; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Imidazoles; Male; Myocardial Infarction; Myocardium; Oxidoreductases; Thromboxane-A Synthase; Time Factors

1983
Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease.
    British journal of clinical pharmacology, 1983, Volume: 15 Suppl 1

    Topics: Adult; Aged; Angina Pectoris; Coronary Circulation; Coronary Disease; Hemodynamics; Humans; Imidazoles; Middle Aged; Myocardium; Oxidoreductases; Platelet Aggregation; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes

1983
Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
    Journal of the American College of Cardiology, 1990, Volume: 16, Issue:3

    Topics: Animals; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Epinephrine; Epoprostenol; Ergolines; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; Male; Pentanoic Acids; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin Antagonists; Thromboxane A2; Thromboxane-A Synthase

1990
Pharmacologic effects on coronary microvessels during myocardial ischaemia.
    European heart journal, 1990, Volume: 11 Suppl B

    Topics: Animals; Blood Flow Velocity; Capillary Permeability; Coronary Circulation; Coronary Disease; Coronary Vessels; Erythrocyte Count; Fatty Acids; Gallopamil; Imidazoles; Indomethacin; Microcirculation; Platelet Count; Rats; Thromboxane-A Synthase; Verapamil

1990